{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T07:12:07Z","timestamp":1778310727816,"version":"3.51.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10072-026-09041-0","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T03:19:54Z","timestamp":1776309594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LAMB1-related adult-onset leukoencephalopathy presenting with cognitive decline: diagnostic workup and review of the literature"],"prefix":"10.1007","volume":"47","author":[{"given":"Federica","family":"Palacino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Betto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Ukmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Cattaruzza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Damante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Manganotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8703-6940","authenticated-orcid":false,"given":"Alberto","family":"Benussi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"9041_CR1","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/J.YMGME.2015.01.006","volume":"114","author":"A Vanderver","year":"2015","unstructured":"Vanderver A, Prust M, Tonduti D, Mochel F, Hussey HM, Helman G et al (2015) Case definition and classification of leukodystrophies and leukoencephalopathies. Mol Genet Metab 114:494\u2013500. https:\/\/doi.org\/10.1016\/J.YMGME.2015.01.006","journal-title":"Mol Genet Metab"},{"key":"9041_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/S10048-025-00872-1","volume":"26","author":"J Zamora","year":"2025","unstructured":"Zamora J, Faundes V (2025) Lamb1-associated leukoencephalopathy: a continuum from a prenatal, recessive syndrome to a dominant, adult-onset disorder. Neurogenetics 26:87. https:\/\/doi.org\/10.1007\/S10048-025-00872-1","journal-title":"Neurogenetics"},{"key":"9041_CR3","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/ANA.26242","volume":"90","author":"C Aloui","year":"2021","unstructured":"Aloui C, Herv\u00e9 D, Marenne G, Savenier F, Le Guennec K, Bergametti F et al (2021) End-truncated LAMB1 causes a hippocampal memory defect and a leukoencephalopathy. Ann Neurol 90:962\u2013975. https:\/\/doi.org\/10.1002\/ANA.26242","journal-title":"Ann Neurol"},{"key":"9041_CR4","doi-asserted-by":"publisher","unstructured":"Bonkowsky JL, Keller S (2021) Leukodystrophies in children: Diagnosis, care, and treatment. Pediatrics 148. https:\/\/doi.org\/10.1542\/PEDS.2021-053126\/181065","DOI":"10.1542\/PEDS.2021-053126\/181065"},{"key":"9041_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4161\/CAM.22826","volume":"7","author":"M Aumailley","year":"2013","unstructured":"Aumailley M (2013) The laminin family. Cell Adh Migr 7:48\u201355. https:\/\/doi.org\/10.4161\/CAM.22826","journal-title":"Cell Adh Migr"},{"key":"9041_CR6","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1212\/WNL.0000000000001607","volume":"84","author":"D Tonduti","year":"2015","unstructured":"Tonduti D, Dorboz I, Renaldo F, Masliah-Planchon J, Elmaleh-Berg\u00e8s M, Dalens H et al (2015) Cystic leukoencephalopathy with cortical dysplasia related to LAMB1 mutations. Neurology 84:2195\u20132197. https:\/\/doi.org\/10.1212\/WNL.0000000000001607","journal-title":"Neurology"},{"key":"9041_CR7","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1093\/HMG\/DDAF050","volume":"34","author":"R Yasuda","year":"2025","unstructured":"Yasuda R, Hashimoto H, Oka M, Mok JW, Waqar M, Dauwalder B et al (2025) Functional analysis of pathogenic variants in LAMB1-related leukoencephalopathy reveals genotype\u2013phenotype correlations and suggests its role in glial cells. Hum Mol Genet 34:990\u2013999. https:\/\/doi.org\/10.1093\/HMG\/DDAF050","journal-title":"Hum Mol Genet"},{"key":"9041_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1161\/STROKEAHA.118.023661","volume":"50","author":"AM Drazyk","year":"2019","unstructured":"Drazyk AM, Tan RYY, Tay J, Traylor M, Das T, Markus HS (2019) Encephalopathy in a large cohort of British cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy patients. Stroke 50:283\u2013290. https:\/\/doi.org\/10.1161\/STROKEAHA.118.023661","journal-title":"Stroke"},{"key":"9041_CR9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s002470050672","volume":"29","author":"EN Faerber","year":"1999","unstructured":"Faerber EN, Melvin JJ, Smergel EM (1999) MRI appearances of metachromatic leukodystrophy. Pediatr Radiol 29:669\u2013672. https:\/\/doi.org\/10.1007\/s002470050672","journal-title":"Pediatr Radiol"},{"key":"9041_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S1474-4422(06)70440-9","volume":"5","author":"MS van der Knaap","year":"2006","unstructured":"van der Knaap MS, Pronk JC, Scheper GC (2006) Vanishing white matter disease. Lancet Neurol 5:413\u2013423. https:\/\/doi.org\/10.1016\/S1474-4422(06)70440-9","journal-title":"Lancet Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09041-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09041-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09041-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T06:31:31Z","timestamp":1778308291000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09041-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["9041"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09041-0","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The University of Trieste Ethics Committee approved the study protocol.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The patient involved in this case provided written informed consent for the publication of this case report and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent statement"}},{"value":"AB received speaker honoraria from Angelini Pharma, Eisai, Novo Nordisk and Eli Lilly. The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Potential conflicts of interest"}}],"article-number":"425"}}